The CellSearch (Verdex LLC, San Diego, CA, USA), which is presently the only US Food and Drug Administration (FDA)-approved method for CTCs, is based on the expression of epithelial cell adhesion molecules (EpCAM) on tumor cells [57]. Here, EPCAM is linked to neoplasm.